Biblio Discovery — Demo Discovery Service

10 results for "Hye-Ryeon Kim"

Showing 1–10 · 0.74 seconds · RSS

  1. Journal Article Full text

    Exploring the knowledge structure of Korean physical activity research using topic modeling and keyword network analysis

    So-Eun Lee; Hye-Ryeon Kim; Chang-Hwan Choi

    Journal of Men's Health, Vol. 17 No. 4 · 2021 · English · DOAJ Scopus

    Background and purpose: Information on topics and knowledge structures is an important indicator of trends, prospects and sustainability in research fields. Although many studies on physical activity (PA) have been published in Korea, no studies have been reported to explain knowledge structure…

  2. Journal Article

    The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers

    Hye Ryeon Kim; Soomin Ahn; Hyunji Jo et al.

    Frontiers in Oncology, Vol. 11 · 2021 · English · DOAJ Scopus

    BackgroundTrastuzumab is a HER2-trargeted humanized monoclonal antibody that has been studied as a first-line treatment for patients with HER2-positive advanced gastric cancer (AGC). The effect of anti-HER2 therapy according to tumor mutational burden (TMB) in HER2-positive AGC remains…

  3. Journal Article

    Validation of the Korean Movement Culture Perception (KMCP) Scale Using the Rasch Model: Evidence from Korean and Chinese Populations [version 1; peer review: 2 approved]

    Hye-Ryeon Kim; Eunhye Jo; Xuanshang Jin et al.

    F1000Research, Vol. 15 · 2026 · English · DOAJ Scopus

    Background This study validates the Korean Movement Culture Perception (KMCP) scale, a tool designed to assess Korea's 'Movement Culture' (e.g., K-pop dance, Taekwondo), a key element of the 'Shin Hallyu' (New Korean Wave) characterized by participatory consumption. Using the Rasch model, this…

  4. Journal Article

    Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer

    Hongsik Kim; Ryul Kim; Hyunji Jo et al.

    Therapeutic Advances in Gastroenterology, Vol. 15 · 2022 · English · DOAJ Scopus

    Background: Expression of programmed death-ligand 1 (PD-L1) has been reported to correlate with response to immune checkpoint inhibitors (ICIs) in various tumor types. However, there are few data on the role of PD-L1 expression as a predictive and prognostic biomarker of sensitivity to ICIs in…

  5. Journal Article

    Infectious complications after CAR T-cell therapy: mechanisms, risk stratification, and prevention

    Eunseuk Lee; Ji Hyun Lee; Hye Ryeon Kim et al.

    Blood Research, Vol. 61 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Chimeric antigen receptor (CAR) T-cell therapy is an established treatment for relapsed or refractory B-cell malignancies. Despite therapeutic success, infectious complications remain a major contributor to non-relapsed morbidity and mortality. The risk of infection reflects a prolonged…

  6. Journal Article

    Relationship between METS-IR and thyroid cancer incidence in Korea: a nationwide population-based study

    Hye Ryeon Kim; Minkook Son; Seok Jae Huh et al.

    Frontiers in Oncology, Vol. 14 · 2024 · English · DOAJ Scopus

    BackgroundSeveral previous studies found a positive relationship between metabolic syndrome (MetS) and thyroid cancer (TC) risk. However, there is no research that has studied the relationship between the metabolic score for insulin resistance (METS-IR), a novel surrogate marker for IR, and TC…

  7. Journal Article Full text

    A Study on the Effectiveness of Korean Medicine Treatment for Patients’ Involved in Traffic Accidents and the Analysis of Factors Affecting the Effectiveness of Korean Medicine Treatment - A Retrospective Review

    Seon-Hye Kim; Hye-Ryeon Kim; Won-Suk Sung et al.

    Journal of Acupuncture Research, Vol. 36 No. 1 · 2019 · Korean · DOAJ

    Background This study was conducted to verify the effectiveness and effectiveness-related factors of Korean medicine (KM) treatment for patients who have been involved in traffic accidents (TA). Methods The medical records of 150 TA patients hospitalized in Dongguk University Bundang Oriental…

  8. Journal Article

    HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer

    Hongsik Kim; Ryul Kim; Hye Ryeon Kim et al.

    Frontiers in Oncology, Vol. 12 · 2022 · English · DOAJ Scopus

    HER2 aberrations have been reported as a novel biomarker in HER2-directed therapy or as a prognostic marker in various tumor types. However, in advanced biliary tract cancer (BTC), there have been few studies regarding HER2 aberrations as a biomarker. We analyzed 121 advanced BTC patients who had…

  9. Journal Article

    Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer

    Hongsik Kim MD; Hana Kim MD; Ryul Kim MD, PhD et al.

    Technology in Cancer Research & Treatment, Vol. 20 · 2021 · English · DOAJ Scopus

    Background : High tumor mutational burden (TMB-H) has been reported as a predictive marker to immunotherapy or prognostic marker in various tumor types. However, there has been little study of the role of TMB-H in advanced biliary tract cancer (BTC). Methods : We analyzed 119 advanced BTC patients…

  10. Journal Article

    A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma

    Hyunji Jo; Joohyun Hong; Hongsik Kim et al.

    Frontiers in Oncology, Vol. 12 · 2022 · English · DOAJ Scopus

    PurposePatients with International Metastatic RCC Database Consortium (IMDC) poor risk metastatic renal cell carcinoma (mRCC) rarely respond to first-line tyrosine kinase inhibitors (TKIs) including sunitinib, and carries a very poor prognosis. In recent years, combination therapy involving immune…